Obeticholic acid improves adipose morphometry and inflammation and reduces steatosis in dietary but not metabolic obesity in mice.
about
Macrophage functions in lean and obese adipose tissue.Review article: new treatments in non-alcoholic fatty liver disease.Superior reductions in hepatic steatosis and fibrosis with co-administration of a glucagon-like peptide-1 receptor agonist and obeticholic acid in mice.Metabolic and hepatic effects of liraglutide, obeticholic acid and elafibranor in diet-induced obese mouse models of biopsy-confirmed nonalcoholic steatohepatitis.The selective peroxisome proliferator-activated receptor-delta agonist seladelpar reverses nonalcoholic steatohepatitis pathology by abrogating lipotoxicity in diabetic obese mice.Obeticholic acid protects against hepatocyte death and liver fibrosis in a murine model of nonalcoholic steatohepatitis.
P2860
Obeticholic acid improves adipose morphometry and inflammation and reduces steatosis in dietary but not metabolic obesity in mice.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
Obeticholic acid improves adip ...... not metabolic obesity in mice.
@en
Obeticholic acid improves adip ...... not metabolic obesity in mice.
@nl
type
label
Obeticholic acid improves adip ...... not metabolic obesity in mice.
@en
Obeticholic acid improves adip ...... not metabolic obesity in mice.
@nl
prefLabel
Obeticholic acid improves adip ...... not metabolic obesity in mice.
@en
Obeticholic acid improves adip ...... not metabolic obesity in mice.
@nl
P2093
P2860
P356
P1433
P1476
Obeticholic acid improves adip ...... not metabolic obesity in mice
@en
P2093
Fahrettin Haczeyni
Geoffrey C Farrell
George N Ioannou
Isabelle A Leclercq
Laurence Poekes
Matthew M Yeh
Narcissus C Teoh
Vanessa Barn
W Geoffrey Haigh
P2860
P304
P356
10.1002/OBY.21701
P577
2016-11-02T00:00:00Z